Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Oral Health
Published in: BMC Oral Health 1/2023

Open Access 01-12-2023 | Metastasis | Research

Increased levels of PD1 and glycolysis in CD4+ T cells are positively associated with lymph node metastasis in OSCC

Authors: Kun Wu, Nannan Han, Yuanyuan Mao, Yan Li

Published in: BMC Oral Health | Issue 1/2023

Login to get access

Abstract

Background

Cervical lymph node metastasis is one of the poorest prognostic factors in oral squamous cell carcinoma (OSCC). Activated immune cells generally have metabolic abnormalities in the tumour microenvironment. However, it is unknown whether abnormal glycolysis in T cells could facilitate metastatic lymph nodes in OSCC patients. The aim of this study was to investigate the effects of immune checkpoints in metastatic lymph nodes and determine the correlation between glycolysis and immune checkpoint expression in CD4+ T cells.

Methods

Flow cytometry and immunofluorescence staining were used to analyse the differences in CD4+ PD1+ T cells between metastatic lymph nodes (LN+) and negative lymph nodes (LN−). RT‒PCR was performed to detail the expression of immune checkpoints and glycolysis-related enzymes in LN+ and LN−.

Results

The frequency of CD4+ T cells decreased in LN+ patients (p = 0.0019). The PD1 expression of LN+ increased markedly compared to that of LN− (p = 0.0205). Similarly, the PD1 of CD4+ T cells in LN+ increased significantly compared to that of LN−. Additionally, glycolysis-related enzyme levels in CD4+ T cells from LN+ patients were dramatically higher than those in LN− patients. PD1 and Hk2 expression in CD4+ T cells was also increased in LN+ OSCC patients with prior surgical treatment compared to those without.

Conclusions

These findings suggest that lymph node metastasis and recurrence in OSCC are associated with increases in PD1 and glycolysis in CD4+ T cells; this response may serve as a potential regulator of OSCC progression.
Appendix
Available only for authorised users
Literature
1.
Wu K, Jiang Y, Zhou W, Zhang B, Li Y, Xie F, Zhang J, Wang X, Yan M, Xu Q, et al. Long noncoding RNA RC3H2 facilitates Cell Proliferation and Invasion by Targeting MicroRNA-101-3p/EZH2 Axis in OSCC. Mol Ther Nucleic Acids. 2020;20:97–110.CrossRefPubMedPubMedCentral
2.
Biswas NK, Das C, Das S, Maitra A, Nair S, Gupta T, D’Cruz AK, Sarin R, Majumder PP. Lymph node metastasis in oral cancer is strongly associated with chromosomal instability and DNA repair defects. Int J Cancer. 2019;145(9):2568–79.CrossRefPubMed
3.
Isola G, Santonocito S, Distefano A, Polizzi A, Vaccaro M, Raciti G, Alibrandi A, Li Volti G. Impact of periodontitis on gingival crevicular fluid miRNAs profiles associated with cardiovascular disease risk. J Periodontal Res. 2023;58(1):165–74.CrossRefPubMed
4.
Isola G, Giudice AL, Polizzi A, Alibrandi A, Patini R, Ferlito S. Periodontitis and tooth loss have negative systemic impact on circulating progenitor cell levels: a clinical study. Genes (Basel) 2019, 10(12).
5.
Polizzi A, Santonocito S, Lo Giudice A, Alibrandi A, De Pasquale R, Isola G. Analysis of the response to two pharmacological protocols in patients with oral lichen planus: a randomized clinical trial. Oral Dis. 2023;29(2):755–63.CrossRefPubMed
6.
He W, Zhang H, Han F, Chen X, Lin R, Wang W, Qiu H, Zhuang Z, Liao Q, Zhang W, et al. CD155T/TIGIT signaling regulates CD8(+) T-cell metabolism and promotes Tumor Progression in Human gastric Cancer. Cancer Res. 2017;77(22):6375–88.CrossRefPubMed
7.
Thompson ED, Zahurak M, Murphy A, Cornish T, Cuka N, Abdelfatah E, Yang S, Duncan M, Ahuja N, Taube JM, et al. Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma. Gut. 2017;66(5):794–801.CrossRefPubMed
8.
Han X. Chen, Lieping: Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future.
9.
Jie HB, Srivastava RM, Argiris A, Bauman JE, Kane LP, Ferris RL. Increased PD-1(+) and TIM-3(+) TILs during Cetuximab Therapy inversely correlate with response in Head and Neck Cancer Patients. Cancer Immunol Res. 2017;5(5):408–16.CrossRefPubMedPubMedCentral
10.
Frauwirth KA, Riley JL, Harris MH, Parry RV, Rathmell JC, Plas DR, Elstrom RL, June CH, Thompson CB. The CD28 signaling pathway regulates glucose metabolism. Immunity. 2002;16(6):769–77.CrossRefPubMed
11.
Parry RV, Chemnitz JM, Frauwirth KA, Lanfranco AR, Braunstein I, Kobayashi SV, Linsley PS, Thompson CB, Riley JL. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol. 2005;25(21):9543–53.CrossRefPubMedPubMedCentral
12.
13.
Maciver NJ, Jacobs SR, Wieman HL, Wofford JA, Coloff JL. Rathmell JCJJoLB: glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. 2008, 84.
14.
Atreya I, Schimanski CC, Becker C, Wirtz S, Dornhoff H, Schnurer E, Berger MR, Galle PR, Herr W, Neurath MF. The T-box transcription factor eomesodermin controls CD8 T cell activity and lymph node metastasis in human colorectal cancer. Gut. 2007;56(11):1572–8.CrossRefPubMedPubMedCentral
15.
16.
Broggi M, Schmaler M, Lagarde N, Rossi SWJJVE. Isolation of murine lymph node stromal cells. 2014(90).
17.
Eckert N, Permanyer M, Yu K, Werth K, Förster R. Chemokines and other mediators in the development and functional organization of lymph nodes. Immunol Rev. 2019;289(1):62–83.CrossRefPubMed
18.
Gasteiger G, Ataide M, Kastenmüller W. Lymph node - an organ for T-cell activation and pathogen defense. Immunol Rev. 2016;271(1):200–20.CrossRefPubMed
19.
20.
Palmer CS, Ostrowski M, Balderson B, Christian N, Crowe SM. Glucose metabolism regulates T cell activation, differentiation, and functions. Front Immunol. 2015;6:1.CrossRefPubMedPubMedCentral
21.
Speiser DE, Ho PC, Verdeil GJNRI. Regulatory circuits of T cell function in cancer. 2016.
22.
Borst J, Ahrends T, Bąbała N, Melief CJM, Kastenmüller W. CD4(+) T cell help in cancer immunology and immunotherapy. Nat Rev Immunol. 2018;18(10):635–47.CrossRefPubMed
23.
Ho WY, Yee C, Greenberg PD. Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends. J Clin Investig. 2002;110(10):1415–7.CrossRefPubMedPubMedCentral
24.
Chang MC, Chiang CP, Lin CL, Lee JJ, Hahn LJ, Jeng JH. Cell-mediated immunity and head and neck cancer: with special emphasis on betel quid chewing habit. Oral Oncol. 2005;41(8):757–75.CrossRefPubMed
25.
Crespo J, Sun H, Welling TH, Tian Z. Zou WJCOiI: T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment. 2013, 25(2):214–21.
26.
Brown M, Assen FP, Leithner A, Abe J, Schachner H, Asfour G, Bago-Horvath Z, Stein JV, Uhrin P, Sixt MJS. Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice. 2018, 359(6382):1408–11.
27.
Shin DS, Ribas AJCOiI. The evolution of checkpoint blockade as a cancer therapy: what’s here, what’s next? 2015, 33:23–35.
28.
Karim R, Jordanova ES, Piersma SJ, Kenter GG, Chen L, Boer JM, Melief CJ, van der Burg SH. Tumor-expressed B7-H1 and B7-DC in relation to PD-1 + T-cell infiltration and survival of patients with cervical carcinoma. Clin Cancer Res. 2009;15(20):6341–7.CrossRefPubMed
29.
Mattox AK, Lee J, Westra WH, Pierce RH, Ghossein R, Faquin WC, Diefenbach TJ, Morris LG, Lin DT, Wirth LJ, et al. PD-1 expression in Head and Neck squamous cell Carcinomas derives primarily from functionally anergic CD4(+) TILs in the Presence of PD-L1(+) TAMs. Cancer Res. 2017;77(22):6365–74.CrossRefPubMedPubMedCentral
30.
Seifert AM, Eymer A, Heiduk M, Wehner R, Seifert LJC. PD-1 expression by Lymph Node and Intratumoral Regulatory T cells is Associated with Lymph Node Metastasis in Pancreatic Cancer. 12(10):2756.
31.
Terada H, Shimode Y, Furukawa M, Sato Y, Hanai NJM. The utility of Ultrasonography in the diagnosis of cervical lymph nodes after Chemoradiotherapy for Head and Neck squamous cell carcinoma. 2021, 57(5).
32.
Magnano M, Bussi M, Stefani AD, Milan F, Lerda W, Ferrero V, Gervasio F, Ragona R, Gabriele P. Valente GJAo-l: prognostic factors for head and neck tumor recurrence. 1995, 115(6):833–8.
33.
Ren X, Wu H, Lu J, Zhang Y, Liang ZJCB, Therapy. PD1 protein expression in tumor infiltrated lymphocytes rather than PDL1 in tumor cells predicts survival in triple-negative breast cancer. 2018, 19(5):00–0.
34.
O’Sullivan D, Sanin DE, Pearce EJ, Pearce ELJNRI. Metabolic interventions in the immune response to cancer. 2019, 19(5):1.
35.
Increased Tumor Glycolysis. Characterizes Immune Resistance to adoptive T cell therapy %J Cell Metabol. 2018:S1550413118301785.
36.
Bengsch B, Johnson AL, Kurachi M, Odorizzi PM, Pauken KE, Attanasio J, Stelekati E, McLane LM, Paley MA, Delgoffe GM, et al. Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8(+) T cell exhaustion. Immunity. 2016;45(2):358–73.CrossRefPubMedPubMedCentral
37.
Renner K, Bruss C, Schnell A, Koehl G, Kreutz MJCR. Restricting glycolysis preserves T cell effector functions and augments checkpoint therapy. 2019, 29(1):135–150e139.
Metadata
Title
Increased levels of PD1 and glycolysis in CD4+ T cells are positively associated with lymph node metastasis in OSCC
Authors
Kun Wu
Nannan Han
Yuanyuan Mao
Yan Li
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
Metastasis
Published in
BMC Oral Health / Issue 1/2023
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-023-03043-6

Other articles of this Issue 1/2023

BMC Oral Health 1/2023 Go to the issue

Research

Comparison the accuracy of a novel implant robot surgery and dynamic navigation system in dental implant surgery: an in vitro pilot study

Research

Perceptual difference of smile aesthetics between 2-dimensional photographs and 3-dimensional dentofacial images: a cross-sectional study

Research

Effect of shelf-storage temperature on degree of conversion and microhardness of composite restorative materials

Research

Temporomandibular disorder severity and its association with psychosocial and sociodemographic factors in Turkish adults

Research

Prevalence of different stages of periodontal diseases among a sample of young adult obese Egyptian patients: a hospital based Cross-sectional study over 1 year

Research

Decomposing socioeconomic inequalities in dental caries among Chinese adults: findings from the 4th national oral health survey